After consultation with FDA, today we are pleased to announce that BD is ready to begin remediation of our February 4, 2020 software recall with the release of BD Alaris™ System software v12.1.2 and associated ancillary software as part of our medical necessity program Click here to learn more. https://www.bd.com/en-us/support/alerts-and-notices/recall-and-distribution-hold-of-the-bd-alaris-system At BD, we are committed to patient safety and the safe use of the BD Alaris™ System. As part of this commitment, BD has developed an enhanced Medication Safety Program for custom concentration infusions to provide customers additional education and support. This multi-faceted program includes enhanced training materials, webinars (https://sso2.carefusion.com/idp/startSSO.ping?PartnerSpId=https://bd.csod.com/&TargetResource=https://bd.csod.com%252fDeepLink%252fProcessRedirect.aspx%253fmodule%253dlodetails%2526lo%253d604eff51-70cc-4a86-b44c-a1d7dc0ac2cd%20) and access to our expert BD pharmacy and clinical consultants. The Institute for Safe Medication Practices (ISMP) and the American Society of Health System Pharmacists (ASHP) have highlighted a number of best practices when using custom concentrations. BD is committed to supporting customers in implementing these best practices to increase medication safety. BD strongly encourages customers to: ◦Implement best practice recommendations stated in the ISMP Smart Pump Custom Concentrations without Hard “Low Concentration” Alerts Can Lead to Patient Harm | Institute for Safe Medication Practices.https://www.ismp.org/sites/default/files/attachments/2018-08/NurseAdviseERR201808_0.pdf ◦Join ASHP’s Standardize 4 Safety Initiative and adopt national standardized concentrations outlined in the ASHP Standardize 4 Safety Initiative.https://www.ashp.org/Pharmacy-Practice/Standardize-4-Safety-Initiative ◦Use the resources available on this website to further educate and train your staff on the risks and proper practices for custom concentration programming. ◦Leverage BD’s pharmacy and clinical consultants to support your efforts in analyzing your data set and implementing best practices on using custom concentrations. If you require further assistance, please contact BD Alaris Support at 888-562-6018 for questions about this notification or shipping an Alaris device to BD for repair. For product complaints, please contact Customer Advocacy at 888-812-3266. If you need additional guidance on any of these issues, schedule time to speak with a BD clinical or pharmacy consultant, call 858-617-1316. Training and Other Resources •Listen to on-demand webinar training led by BD experts--https://sso2.carefusion.com/idp/startSSO.ping?PartnerSpId=https://bd.csod.com/&TargetResource=https://bd.csod.com%252fDeepLink%252fProcessRedirect.aspx%253fmodule%253dlodetails%2526lo%253d604eff51-70cc-4a86-b44c-a1d7dc0ac2cd •Clinical quick reference: Programming an Infusion with a Custom Concentration Entry--https://www.bd.com/documents/guides/tip-sheets/IF_Alaris-Custom-Concentration-Tip-Sheet_LAYOUT-LETTER-SIZE-FINAL.pdf •Pharmacy quick reference: Hard minimum concentration limits--https://www.bd.com/documents/alerts/1910004016-20%20Pharmacy%20Best%20Practice%20Guide-Custom%20Conc-LAYOUT-letter%20size%20FINAL.pdf